Back to Journals

Pharmacogenomics and Personalized Medicine

Dr Bluth

Department of Pathology, Wayne State University School of Medicine, United States

Dr Bluth

Dr Martin H. Bluth received his Doctor of Philosophy (Immunology) from SUNY Health Science Center at Brooklyn in 1997 and his Doctor of Medicine in 1999. He is Board Certified in Clinical Pathology/Laboratory Medicine and in Blood Banking/Transfusion Medicine. Dr Bluth is currently Professor of Pathology and Director of Translational Research at Wayne State School of Medicine and Associate Director of the Transfusion Service at Detroit Medical Center/Harper Hospital System in Detroit Michigan, USA. He has co-authored over 80 book chapters, abstracts and manuscripts and holds over 15 New Inventions and technologies many of which are patented or pending. He is Vice President of BioMedica Management Corporation, on the Board of Directors of FirstPoint Biotech venture fund and has recently pioneered biomarker discovery platforms for use towards clinical applications and entrepreneurial start up companies.

See the interview with Dr Martin Bluth about the new Detroit Patent Office (January 2012).

Editorial Board

Hiltrud Brauch, Deputy Head, the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.

Carolyn Compton, Professor of Life Sciences; Chief Medical Officer of the Complex Adaptive Systems Initiative, Arizona State University. Professor of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine.

Vicki Ellingrod, Clinical Social and Administrative Sciences, College of Pharmacy and Medicine, University of Michigan, MI, USA

Takahisa Furuta, Center for Clinical Research, Hamamatsu University School of Medicine, Hamamatsu, Japan

Jing Li, Department of Pharmacology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA

Qing Ma, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, NY, USA

Anke-Hilse Maitland-van der Zee, Professor of Precision Medicine in Respiratory Diseases, Faculty of Medicine, University of Amsterdam, Netherlands.

Stephan Mielke, Division of Hematology and Oncology, Department of Internal Medicine II, Julius Maximilian University of Wuerzburg, Wuerzburg, Germany

Gene Morse, Professor, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, NY, USA

Wolfgang Sadee, Felts Mercer Professor of Medicine and Chair; Pharmacology Director, Program in Pharmacogenomics The Ohio State University, USA.

Gaetano Santulli, Research Scholar, Columbia University Medical Center, College of Physicians & Surgeons, New York, NY, USA

Andrew Somogyi, Professor of Clinical and Experimental Pharmacology, Adelaide Medical School, University of Adelaide, Australia.

Michael A. Tainsky, Professor, Department of Oncology, Fred and Barbara Erb Endowed Professor of Cancer Genetics, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA

John van den Anker, Professor, Children's National Medical Center, Washington, D.C., USA

Xifeng Wu, Professor and Chair, Department of Epidemiology, Division of Cancer Prevention and Population Sciences. Director, Center for Translational and Public Health Genomics, The University of Texas MD Anderson Cancer Center, USA.

Yuan Zhao, Biotherapeutics Group, National Institute for Biological Standards and Control, UK